2013 Data Epilepsy Therapy 
Cannabis Law Report
JULY 27, 2021
and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Under the Leadership of Nicolas Schlienz, Ph.D., About Realm of Caring.
The Cannigma
JULY 17, 2022
You don’t need a medical condition or a paid subscription – the ROC serves curious consumers, medical professionals, and anyone else who is looking to better their life through cannabinoid therapies. The advice and suggestions are based on data, including the results from ROC’s own cannabis research registry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healer
JUNE 28, 2019
Patients with advanced cancer who have pain that responds poorly to opioid therapy pose a clinical challenge. Adopted Name for Sativex , which does not yet have an INN), a novel cannabinoid formulation, is undergoing investigation as add-on therapy for this population. Nabiximols (Nabiximols is the U.S. Abstract: Medical Study .
Cannabis Law Report
JANUARY 20, 2022
Merger also to support nationwide expansion of Eleusis’s subsidiary Andala, which manages in-network drug therapy clinics targeting the “last mile” challenge of psychedelic care delivery to address a potential $7 billion U.S. Founded in 2013, Eleusis is dedicated to transforming psychedelics into medicines.
Cannabis Law Report
JULY 12, 2019
This differs sharply from the conventional course of cannabis medicine, which is to use whole, clean plant extracts to treat epilepsy and to gradually discontinue use of conventional pharmaceuticals. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC. Lancet Neurol Dec 23 2015.
Cannabis Law Report
NOVEMBER 24, 2021
Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. At the same time, the outlook on cannabis research data is largely positive. Refractory paediatric epilepsy. Palliative care indications.
Green Relief
MAY 13, 2018
It is the most commonly identified cause of epilepsy among adults. government-sponsored scientific research – and to extensive anecdotal accounts from medical marijuana patients – which highlight the potential of cannabinoid-based therapies for TBI. Hypothermia is typically the go-to therapy for treating newborn infants after a stroke.
Expert insights. Personalized for you.
105 
Let's personalize your content